Brief: Dr. Lal Pathlabs Q2 Consol Net Profit 1.29 Bln Rupees
Oct 23 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* Q2 CONSOL NET PROFIT 1.29 BILLION RUPEES; IBES EST. 1.26
BILLION
RUPEES
* Q2 CONSOL REVENUE FROM OPERATIONS 6.60 BILLION RUPEES;
IBES EST.
6.72 BILLION RUPEES
* DIVIDEND 6 RUPEES PER SHARE
* OM PRAKASH MANCHANDA WILL BE STEPPING DOWN AS MANAGING
DIRECTOR
Source text for Eikon: ID:
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise